Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update

March 27, 2023

https://www.globenewswire.com/news-release/2023/03/27/2635212/0/en/Acer-Therapeutics-Reports-Q4-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html

NEWTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for Q4 and full year ended December 31, 2022, and provided an update on the Company’s recent corporate developments.

Read more at globenewswire.com

Related news for (ACER)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.